The previously reported high affinity of those particles to SR-B1 and their increased efficacy in mediating bidirectional lipid flux reduces the net cholesterol-removing capacity of those particles, thereby making them less effective in killing pancreatic-cancer cells. This evidence concerns the gene SCARB1 and cancer.